Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,512
Closed -$441K 456
2023
Q3
$441K Buy
19,512
+13,893
+247% +$394K 0.06% 257
2023
Q2
$180K Buy
+5,619
New +$180K 0.03% 423
2020
Q3
Sell
-1,647
Closed -$127K 299
2020
Q2
$127K Buy
+1,647
New +$98.6K 0.01% 410
2020
Q1
Sell
-3,678
Closed -$294K 401
2019
Q4
$294K Buy
+3,678
New +$247K 0.04% 284

Other funds holding AGEN

Caxton Associates (New York)'s AGEN Position: Q4 2023 in Review

Caxton Associates (New York) sold out of Agenus (AGEN) in Q4 2023, closing a stake of 19,512 shares — an estimated $441K sold.

Caxton Associates (New York) first reported a position in AGEN in Q4 2019 and held it in 4 quarters. The position peaked at $441K in Q3 2023. 169 funds tracked by Wall St. Rank hold AGEN as of Q4 2023.

  • Caxton Associates (New York) reported no remaining Agenus position as of Q4 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 19,512 Agenus shares in Q4 2023, an estimated $441K.
  • Caxton Associates (New York) first reported a position in Agenus in Q4 2019 and held it in 4 quarters.
  • Caxton Associates (New York)'s Agenus position peaked at $441K in Q3 2023.
  • 169 funds tracked by Wall St. Rank held Agenus as of Q4 2023.

Based on Caxton Associates (New York)'s 13F filing for Q4 2023, filed 14 Feb 2024.